Contractor profile

Merck Sharp & Dohme LLC

FY2026 ended Sep 30 · data still posting · data as of 2026-11-01†

† DoD contract data posts to USAspending about 90 days after award.

prime recipient of federal awards · UEI FCFDA78HKKG2 Source
$2.3B
Obligated
FY2026 · data still posting
4
Funding agencies
100%
From Health and Hum…
0%
Non-competed
4
States
3
Industries

In FY2026, Merck Sharp & Dohme LLC received $2.3B in federal awards from 4 agencies, 100% of it from the Department of Health and Human Services. Across FY2020 to FY2026 its recorded total is $18B. FY2026 ended Sep 30 and its data is still posting. Computed

Where this money comes from

Source
FUNDING AGENCIES
MERCK SHARP & DOHME LLC
HHS
$2.3B
3 other agencies
$0B
Merck Sharp & Dohme LLC
$2.3B
FY2026 obligated
band width = obligations · FY2026 · source: USASpending.gov

Where the work lands

Source
New Jersey$2M
Tennessee$396K
Pennsylvania$18K

State breakdown available for less than 1% of obligations shown

Key takeaways

Computed
FY2026 ended Sep 30 · data still posting · data as of 2026-11-01
  • Merck Sharp & Dohme LLC received $2.3B in federal obligations in FY2026 (data still posting), compared with $2.9B in FY2025.
  • It ranked #47 among federal contractors by contract obligations in FY2026 (data still posting).
  • The Department of Health and Human Services accounted for 99% of it.
  • Its largest recorded industry was Pharmaceutical Preparation Manufacturing, at $2.3B.

Obligations by year

Computed
$1.9B
FY20
$2.8B
FY21
$3.1B
FY22
$2.1B
FY23
$2.9B
FY24
$2.9B
FY25
$2.3B
FY26 partial
▲ 52%
FY20 to FY25

Awards

Source

Largest active awards by total value

Awards whose period of performance overlaps FY2026, by the amount obligated on each so far.

AwardIDAgencyObligatedStartEndPlace
Contract HHSO100201700012CHHSO100201700012CDepartment of Health and Human Services$236.3M2017-09-282027-09-27New Jersey
Ervebo Procurement75A50124C00057Department of Health and Human Services$156M2024-09-302034-09-29New Jersey

Largest FY2026 awards

Awards that started in FY2026, by the amount obligated on each so far.

No award on record started in FY2026.

What it does (NAICS / PSC)

Pharmaceutical Preparation Manufacturing$2.3B
Refrigerated Warehousing and Storage$1.6M

Competition

0%non-competed (often called no-bid), of $2.3B in contract obligations in FY2026Computed

This describes how contracts were awarded, not wrongdoing.

Similar federal contractors

Computed
Mckesson Corporation$14.9B
Pfizer Inc$1.1B
Glaxosmithkline, LLC$1.1B
Sanofi Vaccines US Inc.$734.4M
Emergent Biosolutions Canada Inc$118.3M
Exelan Pharmaceuticals Inc$96.2M
Canadian Commercial Corporation$16.4M
Trillamed LLC$1.1M

Corporate family

Single registration: no combined family.

Related

Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are Source; figures we calculate are Computed; links we infer (corporate parents, districts, similar contractors, connections between records) are Inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.